Jean-Luc M. Lemercier, CVP, EMEACLA and JAPAC at Edwards Lifesciences Corp (EW), sold 14,400 shares at $91.68 ($1.3M) on 2024-03-11, disclosed to the SEC on 2024-03-11.
Scheduled sale ($1.3M) by CVP, EMEACLA and JAPAC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EW | SELL | 2023-05-09 | $1.2M | — | Filing → |
| EW | SELL | 2023-04-06 | $552K | — | Filing → |
| EW | SELL | 2023-03-08 | $1.0M | — | Filing → |